According to several studies, the high level of genomic structural alterations is characteristic of BRCA1 or BRCA2 inactivation (so called BRCAness) in triple-negative breast and serous ovarian carcinomas [25–27]. Here, BRCA1 is linked to ovarian serous carcinoma.